目前和新的治疗方法对异性胃肠道疾病
Giovanni Marasco1,2, Pierfrancesco Visaggi3, Mariagiulia Vassallo1,2
1IRCCS Azienda Ospedaliero, Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.
酸性胃肠道疾病 (EGIDs) 涉及富含酸素的肠道炎症. 本综述涵盖了对EGIDs的当前和新兴治疗方法,如eosinophilic食道炎等.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 生性胃肠道疾病 (EGIDs) 是一种日益增长的疾病群体,其特征是生细胞在肠道透.
- EGID包括埃索诺菲尔性食道炎 (EoE),胃炎 (EoG),肠炎 (EoN) 和大肠炎 (EoC),每个都有不同的或重叠的症状.
研究的目的:
- 为各种EGID提供当前和研究中的治疗方法的最新概述.
- 突出 EGID 诊断和治疗的不断变化的格局.
主要方法:
- 该综述综合了现有文献和正在进行的临床试验的信息.
- 专注于EGID的诊断标准,流行病学数据和治疗策略.
主要成果:
- EoE发病率正在增加,而关于非 EoE EGID 的数据不那么全面,但显示出明显的流行率.
- 诊断依赖于症状,内镜活检,并排除了eosinophilia的其他原因.
- 在EGID谱中存在重叠的症状和疾病实体.
结论:
- 消化道疾病代表了消化道病理学的重要和不断扩大的领域.
- 对新型治疗方法的研究,包括向疗法和单克隆抗体,正在迅速推进.
- 对于管理EGID来说,全面了解现有和正在研究的药物至关重要.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
